Protein kinases
    3.
    发明申请
    Protein kinases 审中-公开
    蛋白激酶

    公开(公告)号:US20060121475A1

    公开(公告)日:2006-06-08

    申请号:US10526722

    申请日:2003-09-05

    摘要: The present invention relates to novel proteins, termed INSP081, INSP082, and INSP091, herein identified as members of the Germinal Center Kinase (GCK) subfamily of the STE20 family of protein kinases, preferably as NCK-interacting kinases (NIKs) and more preferably as NIK-like embryo specific kinases (NESKs), and to the use of these and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease.

    摘要翻译: 本发明涉及称为INSP081,INSP082和INSP091的新蛋白质,其在本文中被鉴定为STE20家族蛋白激酶的生发中心激酶(GCK)亚家族的成员,优选作为NCK相互作用的激酶(NIK),更优选为 NIK样胚胎特异性激酶(NESKs),以及来自编码基因的这些和核酸序列在疾病的诊断,预防和治疗中的应用。

    Chorionic somatomammotropin hormone splice variants
    6.
    发明申请
    Chorionic somatomammotropin hormone splice variants 审中-公开
    绒毛膜促生长激素拼接变体

    公开(公告)号:US20070032416A1

    公开(公告)日:2007-02-08

    申请号:US10540179

    申请日:2003-12-22

    CPC分类号: C07K14/57518

    摘要: The invention is based on the discovery that INSP100 is a splice variant of human chorionic somatomammotropin hormone 2 (HCS-B; Q14407) and that INSP104 is a splice variant of human chorionic somatomammotropin hormone 1 (hCS-A;P01243). The invention relates to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease. This invention relates to novel proteins, termed INSP100 and INSP104, herein identified as novel splice variants of human Chorionic somatomammotropin hormone 2 (hCS-B; Q14407) and human Chorionic somatomammotropin hormone 1 (hCS-A; P01243) respectively and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease. The variants have an altered A-B loop and are therefore predicted to possess altered receptor binding properties. All publications, patents and patent applications cited herein are incorporated in full by reference.

    摘要翻译: 本发明基于以下发现:INSP100是人绒毛膜促生长激素激素2(HCS-B; Q14407)的剪接变体,INSP104是人绒毛膜促生长激素1(hCS-A; P01243)的剪接变体。 本发明涉及来自编码基因的这些蛋白质和核酸序列在疾病的诊断,预防和治疗中的用途。 本发明涉及分别命名为INSP 100和INSP 104的新型蛋白质,其分别被鉴定为人绒毛膜促生长激素激素2(hCS-B; Q14407)和人绒毛膜促生长激素1(hCS-A; P 01243)的新型剪接变体, 使用这些蛋白质和核酸序列从编码基因中诊断,预防和治疗疾病。 变体具有改变的A-B环,因此预测具有改变的受体结合性质。 本文引用的所有出版物,专利和专利申请通过引用全部并入。

    Il-8-like proteins
    7.
    发明申请
    Il-8-like proteins 审中-公开
    II-8样蛋白

    公开(公告)号:US20060275259A1

    公开(公告)日:2006-12-07

    申请号:US10540180

    申请日:2003-12-19

    IPC分类号: A61K38/20 C07K14/54

    CPC分类号: C07K14/5421

    摘要: This invention relates to proteins, termed INSP093, herein identified as secreted proteins, in particular, as members of the Interleukin (IL) 8-like chemokine family and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.

    摘要翻译: 本发明涉及称为INSP093的蛋白质,本文鉴定为分泌蛋白质,特别是作为白细胞介素(IL)8样趋化因子家族的成员,以及来自编码基因的这些蛋白质和核酸序列在诊断中的应用, 预防和治疗疾病。